| Catalog Number |
ACMA00065295 |
| Description |
Tafamidis is intended for Pharmaceuticals applications. It is indicated to treat cardiomyopathy of wild type or hereditary transthyretin-mediated amyloidosis in adults. All information about [13C6]-Tafamidis is provided in the MSDS. We deliver compounds with high purity levels and a comprehensive Certificate of Analysis. |
| Synonyms |
[13C6]-FX-1006A, [13C6]-2-(3,5-dichlorophenyl)-1,3-benzoxazole-6-carboxylic acid |
| Molecular Weight |
314.07 |
| Molecular Formula |
C14H7Cl2NO3 |
| Purity |
≥95% |
| Isotopic Enrichment |
99% 13C |
| Stability |
≥1 year |
| Unlabeled CAS |
594839-88-0 |
Please kindly note that our products and services are for research use only.
